Recently active
Unread page 10
On the live site this tab tracks what you have not read. In this static rendering it shows every topic with activity in the last 45 days, which is the closest honest equivalent — we would rather explain the difference than pretend a static page knows your reading history.
414 topics · page 10 of 14
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
What to include when your question involves a laboratory result
Asking directly, because I could not find a straight answer: What to include when your question involves a laboratory result Question in the title. Context below, and I have tried to include the things people…
|
+8 | 12 | 14k | 2d |
|
Follow-up: The retatrutide phase 2 obesity paper, read closely
The retatrutide phase 2 obesity paper, read closely — setting out what I have, and where I think it stops being reliable. A follow-up question about retatrutide phase 2 obesity paper that I did not know to…
|
+19 | 23 | 16k | 2d |
|
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people admit
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people admit Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about…
|
+50 | 55 | 7.8k | 2d |
|
Micro-titration: a disputed topic, argued properly
Micro-titration: a disputed topic, argued properly Writing it up because I had to work it out twice and would rather nobody else did. Two things I would like separated before anyone answers on…
|
+99 | 110 | 61k | 2d |
|
Alcohol: what is documented and what is folklore
Posting this under the heading it deserves: Alcohol: what is documented and what is folklore Everything below is what sits behind that. Alcohol, and specifically the version of it that the documentation does…
|
+120 | 134 | 11k | 2d |
|
What a certificate commits its issuer to — the long version
Asking directly, because I could not find a straight answer: What a certificate commits its issuer to — the long version A documentation question rather than an analytical one. I have a certificate in front…
|
+20 | 26 | 21k | 2d |
|
Impurity thresholds: where the common numbers come from
Impurity thresholds: where the common numbers come from — setting out what I have, and where I think it stops being reliable. I have spent a fortnight trying to pin impurity thresholds down and I want to set…
|
+11 | 15 | 825 | 2d |
|
Why chargeback is not the safety net people assume
Asking directly, because I could not find a straight answer: Why chargeback is not the safety net people assume Asking about the record rather than the transfer. Every order leaves a trail: an order…
|
+22 | 26 | 2.5k | 2d |
|
Coming back to: Preparing for an appointment: one page, three questions
Preparing for an appointment: one page, three questions — setting out what I have, and where I think it stops being reliable. A question about how to describe something to a clinician rather than about the…
|
+51 | 56 | 1.4k | 2d |
|
Coming back to: Time to steady state after a dose increase
Time to steady state after a dose increase Writing it up because I had to work it out twice and would rather nobody else did. Working through the kinetics rather than the pharmacology, because I think the…
|
+104 | 110 | 16k | 2d |
|
Coming back to: A community side-effect dataset, with its response rate and biases
Posting this under the heading it deserves: A community side-effect dataset, with its response rate and biases Everything below is what sits behind that. Community side-effect dataset — I have the observation…
|
+96 | 101 | 33k | 2d |
|
NHS criteria and how they are applied in practice
NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. I was wrong about NHS criteria in a thread last spring and I would like to correct it…
|
+37 | 42 | 31k | 2d |
|
Stepping down deliberately, and how to do it without losing progress — what changed since
Posting this under the heading it deserves: Stepping down deliberately, and how to do it without losing progress — what changed since Everything below is what sits behind that. Something changed and I would…
|
+94 | 99 | 29k | 2d |
|
Forced degradation studies: designing one that is informative
Posting this under the heading it deserves: Forced degradation studies: designing one that is informative Everything below is what sits behind that. Collecting what is known about forced degradation studies…
|
+100 | 106 | 35k | 2d |
|
Designing a personal experiment that could change your mind — one year on
Designing a personal experiment that could change your mind — one year on — setting out what I have, and where I think it stops being reliable. Two things I would like separated before anyone answers on…
|
+74 | 80 | 17k | 2d |
|
Why catalogue breadth is not evidence of anything
Why catalogue breadth is not evidence of anything I have a specific reason for asking rather than idle curiosity, and the context is below. What changes if the standard account of catalogue breadth is wrong?…
|
2 | 38k | 2d | |
|
[2026 update] Why 99.2% and 97.8% on the same lot can both be correct
Why 99.2% and 97.8% on the same lot can both be correct — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to understand what this number means before I…
|
+1 | 5 | 719 | 2d |
|
[2026 update] A report I filed that turned out to be wrong, and the correction
On the subject in the title: A report I filed that turned out to be wrong, and the correction Working notes rather than a conclusion. Structured report rather than an opinion, following the format the…
|
+15 | 19 | 18k | 2d |
|
Batch numbers that do not match the vial label
Batch numbers that do not match the vial label — setting out what I have, and where I think it stops being reliable. Structured question about turnaround and what it signals. I have started recording how long…
|
+43 | 48 | 8.9k | 2d |
|
Coming back to: Payment method and the leverage it gives you, ranked
Payment method and the leverage it gives you, ranked — setting out what I have, and where I think it stops being reliable. A payments question, with the mechanics separated from the money. What I would like…
|
+21 | 26 | 43k | 2d |
|
Second pass at: When your prescriber and the evidence disagree
Second pass at: When your prescriber and the evidence disagree — setting out what I have, and where I think it stops being reliable. What changes if the standard account of prescriber is wrong? I ask because…
|
+51 | 55 | 9.2k | 2d |
|
How shortages have affected compounding permissions
How shortages have affected compounding permissions I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to know what people here actually do about shortages,…
|
+61 | 71 | 3.6k | 2d |
|
Ultrasound and skinfolds: operator dependence in practice
Ultrasound and skinfolds: operator dependence in practice — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on ultrasound and skinfolds. The…
|
+72 | 76 | 2.7k | 2d |
|
Revisiting: Protein density versus volume when you cannot eat much
Revisiting: Protein density versus volume when you cannot eat much Writing it up because I had to work it out twice and would rather nobody else did. I have spent a fortnight trying to pin Protein density…
|
+97 | 108 | 3.6k | 2d |
|
Programming during a large energy deficit
Programming during a large energy deficit — setting out what I have, and where I think it stops being reliable. Programming during a large energy: what I expected, what I found, and the gap between them. I am…
|
+39 | 49 | 36k | 2d |
|
Review: an evidence digest and the citation check that delayed it
On the subject in the title: Review: an evidence digest and the citation check that delayed it Working notes rather than a conclusion. I was wrong about evidence digest in a thread last spring and I would…
|
+13 | 17 | 15k | 2d |
|
Follow-up: UK access routes, dated and sourced
On the subject in the title: UK access routes, dated and sourced Working notes rather than a conclusion. Regional question, dated March 2026, because everything in this category expires. The position differs…
|
+10 | 14 | 27k | 2d |
|
Why the timeline is on the right and not the left — what changed since
Why the timeline is on the right and not the left — what changed since I have a specific reason for asking rather than idle curiosity, and the context is below. What changes if the standard account of…
|
+77 | 81 | 4k | 2d |
|
About the Adverse events category
Serious and unexpected events, how to document them, and where to report them officially. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its…
|
+2 | 6 | 8.7k | 2d |
|
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction
The question in the title: Why a glucagon receptor agonist in a weight-loss compound is not a contradiction I will give what I have already checked below so nobody repeats it. I would like to disagree…
|
+43 | 47 | 19k | 2d |